ImportRefusal LogoImportRefusal

Vetcur Biotec Aps

⚠️ Moderate Risk

FEI: 3009348974 • Haderslev • DENMARK

FEI

FEI Number

3009348974

📍

Location

Haderslev

🇩🇰

Country

DENMARK
🏢

Address

Feldumvej 35, , Haderslev, , Denmark

Moderate Risk

FDA Import Risk Assessment

49.5
LowModerateHighCritical

This firm has a moderate history of FDA import refusals. Some attention may be warranted.

Statistics

9
Total Refusals
4
Unique Violations
8/18/2016
Latest Refusal
8/28/2015
Earliest Refusal

Score Breakdown

Violation Severity
73.6×40%
Refusal Volume
37.0×30%
Recency
0.0×20%
Frequency
90.0×10%
How is this score calculated?

Proprietary Algorithm

  • 40% Violation Severity — AI-assessed (1-10)
  • 30% Refusal Volume — Logarithmic scale
  • 20% Recency — Decays over 5 years
  • 10% Frequency — Refusals per year

© ImportRefusal.com Original Analysis

Violation Summary

2385×

UNSAFE ADD

The article is subject to refusal of admission pursuant to Section 801(a)(3) in that it appears to bear or contain an unsafe food additive within the meaning of section 409.

2605×

FALSE

The article is subject to refusal of admission pursuant to Section 801(a)(3) of the FD&C Act in that it appears to be misbranded within the meaning of Section 403(a)(1 ) of the FD&C Act in that the labeling is false or misleading in any particular.

723×

NEW VET DR

The article is subject to refusal of admission pursuant to Section 801(a)(3) of the Federal Food, Drug, and Cosmetic Act in that it appears to be a new animal drug that is unsafe within the meaning of Section 512(a) of the Federal Food, Drug, and Cosmetic Act as it is not the subject of an approved new animal drug application, conditionally approved new animal drug application, or index listing, and no investigational new animal drug exemption applies.

751×

UNAPPROVED

The article is subject to refusal of admission pursuant to Section 801(a)(3) in that it appears to be a new drug within the meaning of Section 201(p) without an approved New Drug Application (NDA).

Refusal History

DateProductViolationsDivision
8/18/2016
54AML99VITAMIN, N.E.C.
75UNAPPROVED
Division of Northern Border Imports (DNBI)
5/19/2016
66YPL99EXHIBITS - OTHER DRUG RELATED ITEMS N.E.C.
72NEW VET DR
Division of Southeast Imports (DSEI)
5/19/2016
66YPL99EXHIBITS - OTHER DRUG RELATED ITEMS N.E.C.
72NEW VET DR
Division of Southeast Imports (DSEI)
4/15/2016
66VPL99MISCELLANEOUS PATENT MEDICINES, ETC.
72NEW VET DR
Cincinnati District Office (CIN-DO)
8/28/2015
54ALT99VITAMIN, N.E.C.
238UNSAFE ADD
260FALSE
Cincinnati District Office (CIN-DO)
8/28/2015
54ALT99VITAMIN, N.E.C.
238UNSAFE ADD
260FALSE
Cincinnati District Office (CIN-DO)
8/28/2015
54ALT99VITAMIN, N.E.C.
238UNSAFE ADD
260FALSE
Cincinnati District Office (CIN-DO)
8/28/2015
54ALT99VITAMIN, N.E.C.
238UNSAFE ADD
260FALSE
Cincinnati District Office (CIN-DO)
8/28/2015
54ALT99VITAMIN, N.E.C.
238UNSAFE ADD
260FALSE
Cincinnati District Office (CIN-DO)

Frequently Asked Questions

What is Vetcur Biotec Aps's FDA import refusal history?

Vetcur Biotec Aps (FEI: 3009348974) has 9 FDA import refusal record(s) in our database, spanning from 8/28/2015 to 8/18/2016.

What is an FEI number?

FEI stands for Firm Establishment Identifier. It's a unique number assigned by the FDA to identify establishments that manufacture, process, pack, or hold food, drugs, medical devices, or other FDA-regulated products. Vetcur Biotec Aps's FEI number is 3009348974.

What types of violations has Vetcur Biotec Aps received?

Vetcur Biotec Aps has been cited for 4 different violation type(s). Common FDA violations include adulteration (unsafe or unsanitary products), misbranding (incorrect or misleading labels), and regulatory non-compliance.

Where does this information about Vetcur Biotec Aps come from?

All FDA import refusal data for Vetcur Biotec Aps is sourced from the official FDA Data Dashboard (datadashboard.fda.gov), a public government database maintained by the U.S. Food and Drug Administration.

Data sourced from the FDA Data Dashboard, a public database maintained by the U.S. Food and Drug Administration.